Inhibition of respiratory viruses by nasally administered siRNA.
about
Selective gene silencing by viral delivery of short hairpin RNAEctopic expression of miR-126*, an intronic product of the vascular endothelial EGF-like 7 gene, regulates prostein translation and invasiveness of prostate cancer LNCaP cellsRegression of murine lung tumors by the let-7 microRNAAn intronic microRNA silences genes that are functionally antagonistic to its host geneRespiratory viruses other than influenza virus: impact and therapeutic advancesThe promises and pitfalls of RNA-interference-based therapeuticsTherapeutic application of RNAi: is mRNA targeting finally ready for prime time?Whole blood gene expression in infants with respiratory syncytial virus bronchiolitisA single siRNA suppresses fatal encephalitis induced by two different flaviviruses.Epigenetics and miRNA emerge as key regulators of smooth muscle cell phenotype and functionInduction of protective effector immunity to prevent pathogenesis caused by the respiratory syncytial virus. Implications on therapy and vaccine designDirect cytosolic delivery of siRNA using nanoparticle-stabilized nanocapsulesSilencing Viral InfectionRNAi-mediated gene silencing in tick synganglia: a proof of concept studyInhibition of Respiratory Syncytial Virus Infections With Morpholino Oligomers in Cell Cultures and in MicesiRNAs: potential therapeutic agents against hepatitis C virusDelivery of RNAi Therapeutics to the Airways-From Bench to BedsideCurrent prospects for RNA interference-based therapiesA novel 5-lipoxygenase-activating protein inhibitor, AM679, reduces inflammation in the respiratory syncytial virus-infected mouse eyeAerosol Delivery of siRNA to the Lungs. Part 1: Rationale for Gene Delivery SystemsRespiratory syncytial virus NS1 protein colocalizes with mitochondrial antiviral signaling protein MAVS following infectionMicroRNA regulation of human protease genes essential for influenza virus replicationGene silencing: a therapeutic approach to combat influenza virus infections.Eukaryotic translation initiation factor 5A small interference RNA-liposome complexes reduce inflammation and increase survival in murine models of severe sepsis and acute lung injuryA combinatorial library of lipid-like materials for delivery of RNAi therapeutics.Effective treatment of respiratory alphaherpesvirus infection using RNA interference.siRNA silencing of keratinocyte-specific GFP expression in a transgenic mouse skin model.Intracranial administration of P gene siRNA protects mice from lethal Chandipura virus encephalitis.Lipid-like materials for low-dose, in vivo gene silencingPulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus-induced inflammation and infectionAttenuated Salmonella choleraesuis-mediated RNAi targeted to conserved regions against foot-and-mouth disease virus in guinea pigs and swineNon-viral siRNA delivery into the mouse retina in vivo.Drug delivery-mediated control of RNA immunostimulationSelection of potent non-toxic inhibitory sequences from a randomized HIV-1 specific lentiviral short hairpin RNA library.siRNA-based therapy ameliorates glomerulonephritisPharmacologic advances in the treatment and prevention of respiratory syncytial virus.TransKingdom RNA interference: a bacterial approach to challenges in RNAi therapy and delivery.A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus.A status report on RNAi therapeutics.Double-stranded RNA induces sequence-specific antiviral silencing in addition to nonspecific immunity in a marine shrimp: convergence of RNA interference and innate immunity in the invertebrate antiviral response?
P2860
Q21245112-49527ABD-FC91-4141-8038-B58F8CFA5C98Q24604908-BEC574D4-3E18-43F2-A774-41FE9D038808Q24621218-BF10F998-CD32-4F3E-B4E3-62F29C5D73CFQ24653379-DFCC8175-7CF7-49C2-B389-791F2D92D4A9Q24655957-5CD77A16-02CF-49BD-9D40-39737024B204Q24657247-EBD9BE02-5508-4BC3-A310-C20E04CA53F8Q24669624-885D7F74-AA0D-45EF-95EA-B7FEE6952A4CQ24679785-69CA3311-3B4F-4D0C-96FB-2B93302EE2AFQ25255046-97D85776-EB22-4FB5-88C8-2DA7AD28882AQ27006515-AF582B30-9067-45AE-80BF-6BFE08FB01BBQ27021304-B5609FD6-0C9D-493B-AFCC-B17693461D2CQ27339704-665D7906-AA92-4DF7-A922-0DF6FEE60883Q27473399-83693F31-CA86-49CF-A8A3-85911D4A7989Q27486085-B3496AAC-85CA-48F7-85DA-55DB446F0323Q27490424-84474798-321B-4B4E-9CD0-C28A7AA8587EQ27694682-C4997DF0-3D33-4F9A-B424-36E75EC275C4Q28067306-2F4CEDC1-967B-4E94-BCEE-8489B4F88E2EQ28235733-C801E469-CEEC-467E-BC1D-26B15E3DD28CQ28258798-B89679E9-C158-488A-8B51-7C508C14CC38Q28392004-C0AA900E-6294-4984-BB16-CB17C9D12D0CQ28481271-50017CA4-C517-4D52-8DF6-2E2E44CEB916Q28483683-E87ABD47-8619-42F8-B484-311472389E06Q30370880-138EF30E-2E8D-497C-8F8C-B7B619266DA5Q30436677-959AB24E-B1DE-4924-B244-F5D04473E70EQ33330928-CCD6AFA9-939D-4F08-8A5F-B584DA1626B3Q33397374-E34A945F-F449-4126-BB82-06E5689F2CA4Q33454280-8644EEE1-CF87-48A8-B62E-490F115742BDQ33523028-C8C5D614-9F93-4D74-91D2-9D19ADDDBF0EQ33583399-9E4B11A9-B9CE-4AAA-B6DA-3EB3E5FAA92FQ33591425-C1DE991F-9583-4E95-9AAF-AAE53B3AAD68Q33676729-4D91647A-0CED-4787-BC8D-7C709640B7A3Q33710058-6AFAE73D-ADB6-4D70-B49D-C2D09FBD3D1AQ33713938-8828CC9E-593A-412C-B111-1C3B222CCC6FQ33719287-FDE16BAA-FFCF-421C-8134-3CD7A30F74C9Q33748522-70062204-0DA3-4712-B6D8-7E976914BDE0Q33776507-7B673B55-BB7F-40FF-ACB0-26E7E348EC3FQ33848915-96C3763D-967B-4341-8E19-E5F7C6C86834Q33928650-FFADBF1E-53CF-4697-81F0-CD290C3E1A64Q34013891-4110EA0C-7F8C-4C21-8352-8C0C2A625DD0Q34092648-AB433C0F-3F97-478A-9816-9F8A7E8093C6
P2860
Inhibition of respiratory viruses by nasally administered siRNA.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Inhibition of respiratory viruses by nasally administered siRNA.
@en
Inhibition of respiratory viruses by nasally administered siRNA.
@nl
type
label
Inhibition of respiratory viruses by nasally administered siRNA.
@en
Inhibition of respiratory viruses by nasally administered siRNA.
@nl
prefLabel
Inhibition of respiratory viruses by nasally administered siRNA.
@en
Inhibition of respiratory viruses by nasally administered siRNA.
@nl
P2093
P2860
P356
P1433
P1476
Inhibition of respiratory viruses by nasally administered siRNA.
@en
P2093
Alla Musiyenko
Olena Shulyayeva
Sailen Barik
Vira Bitko
P2860
P2888
P356
10.1038/NM1164
P407
P577
2004-12-26T00:00:00Z